Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Known antiischemic agent demonstrates cognition-enhancing effects

Aug. 14, 1998

Three studies confirm efficacy and safety of Chinese AD treatment agent

Aug. 14, 1998

French team discloses newly discovered 5-HT1A agonists

Aug. 14, 1998

Phase III trial of Ampligen for the treatment of CFS now underway

Aug. 14, 1998

New antimigraine drug candidate discussed by Pierre Fabre at IUPHAR meeting

Aug. 13, 1998

Antidepressant efficacy established with new addition to the Ampakine family

Aug. 13, 1998

Joint research project will evaluate ABS-103 for the treatment of epilepsy

Aug. 13, 1998

Sepracor patents single-isomer form of zopiclone for treatment of sleep disorders

Aug. 13, 1998

French team discovers ciproxifan, a histaminergic agent with clinical potential in AD

Aug. 12, 1998

ADIR discovers new compounds with affinity for imidazoline receptors

Aug. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.